State Street
BBNX

State Street’s Beta Bionics BBNX Stock Holding History

State Street’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
970,192
+24,105
+3% +$287K ﹤0.01% 2504
2026
Q1 		$9.48M Buy
946,087
+82,954
+10% +$1.23M ﹤0.01% 2643
2025
Q4 		$26.3M Buy
863,133
+36,831
+4% +$984K ﹤0.01% 2104
2025
Q3 		$16.4M Buy
826,302
+596,307
+259% +$10.5M ﹤0.01% 2346
2025
Q2 		$3.35M Buy
229,995
+124,023
+117% +$1.76M ﹤0.01% 3105
2025
Q1 		$1.3M Buy
+105,972
New +$1.98M ﹤0.01% 3378

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

State Street's BBNX Position: Q2 2026 in Review

State Street increased its Beta Bionics (BBNX) stake by 2.5% in Q2 2026, buying an estimated $287K and bringing the position to 970,192 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2504.

State Street first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $26.3M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • State Street held 970,192 shares of Beta Bionics worth $15.2M as of Q2 2026.
  • State Street bought 24,105 Beta Bionics shares in Q2 2026, an estimated $287K.
  • Beta Bionics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2504 holding.
  • State Street first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • State Street's Beta Bionics position peaked at $26.3M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.